Contact
searchSearch
HMP Global

Volume 14 - Issue 11 - November, 2002

Feature

Vascular Disease
Percutaneous Femoral Artery Angioplasty with Stent-in-Stent Technique and Tirofiban Administration
08/01/2008
Angelo Cioppa, MD; Letizia Lo Muzio, MD; Luigi Salemme, MD; Giovanni Sorropago, MD; Tullio Tesoria, MD; Paolo Rubino, MD; Salvatore L. Battaglia, MD, BS; Vittorio Ambrosini, MD
Percutaneous transluminal angioplasty (PTA) of the femoral artery is one method that has been used for many years, especially for patients with a high level of surgical risk. The use of stents alongside the traditional balloon techniques has...
Percutaneous transluminal angioplasty (PTA) of the femoral artery is one method that has been used for many years, especially for patients with a high level of surgical risk. The use of stents alongside the traditional balloon techniques has...
Percutaneous transluminal...
08/01/2008
Journal of Invasive Cardiology
Case Report
Significant Atheromatous Debris Following Uncomplicated Vein Graft Direct Stenting: Evidence Supporting Routine Use of Distal Pr
08/01/2008
Stephen N. Oesterle, MD; Stuart L. Houser, MD; Thomas Aretz, MD; Brian D. MacNeill, MD; Igor F. Palacios, MD; Harry C. Lowe, MD, MBChB, PhD, FRACP
Massive particulate atheromatous material was observed on histological examination of debris from a Percusurge embolization containment device, used in clinically uncomplicated direct stent coronary vein graft intervention. This is provided...
Massive particulate atheromatous material was observed on histological examination of debris from a Percusurge embolization containment device, used in clinically uncomplicated direct stent coronary vein graft intervention. This is provided...
Massive particulate atheromatous...
08/01/2008
Journal of Invasive Cardiology
Case Report
Percusurge Guardwire Balloon-Associated Thrombus — A Limitation of the Percusurge Distal Protection System
08/01/2008
Ashish Pershad, MD; Gopi Cherukiri, MD; Alex Kirby, MD
Within ten years of coronary artery bypass surgery, up to 66% of saphenous vein grafts either occlude or demonstrate significant atherosclerosis.1 This necessitates either repeat coronary artery bypass grafting or percutaneous coronary...
Within ten years of coronary artery bypass surgery, up to 66% of saphenous vein grafts either occlude or demonstrate significant atherosclerosis.1 This necessitates either repeat coronary artery bypass grafting or percutaneous coronary...
Within ten years of coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
Treatment of Medically Uncontrolled Coronary Artery Spasm in the Normal Coronary Artery with Coronary Stenting
08/01/2008
Milan A. Nedeljkovic, MD, PhD; Branko Beleslin, MD; Miodrag Ostojic, MD, PhD
Coronary artery spasm is localized to a segment of epicardial coronary artery; in most patients, it is superimposed on the angiographically detectable atherosclerotic lesion.1,12 However, it can also occur in coronary arteries that lack...
Coronary artery spasm is localized to a segment of epicardial coronary artery; in most patients, it is superimposed on the angiographically detectable atherosclerotic lesion.1,12 However, it can also occur in coronary arteries that lack...
Coronary artery spasm is...
08/01/2008
Journal of Invasive Cardiology
Case Report
Recurrent Spasm of Radial Artery Graft Mimicking Fixed Stenosis
08/01/2008
Andrew Macina, MD; Mikhail Torosoff, MD, PhD; Robert D. Millar, MD
The radial artery is now frequently used as a conduit for coronary artery bypass grafting (CABG). Spasm of the radial artery conduit has been reported.1 We report a case in which spasm simulates the appearance of a fixed lesion. Case Report....
The radial artery is now frequently used as a conduit for coronary artery bypass grafting (CABG). Spasm of the radial artery conduit has been reported.1 We report a case in which spasm simulates the appearance of a fixed lesion. Case Report....
The radial artery is now...
08/01/2008
Journal of Invasive Cardiology
Case Report
Percutaneous Coronary Intervention in a Sequential Radial Artery Graft Anastomosed to <br />
the Descending Aorta, Left Circumflex Ar
08/01/2008
Jeffrey W. Moses, MD; Yoshio Kobayashi, MD; Nadim Al-Mubarak, MD
Poor long-term patency rates have been documented for saphenous vein grafts; only 50–60% of saphenous vein grafts are patent 10 years post-operation.1 On the other hand, excellent long-term patency of the left internal mammary artery for...
Poor long-term patency rates have been documented for saphenous vein grafts; only 50–60% of saphenous vein grafts are patent 10 years post-operation.1 On the other hand, excellent long-term patency of the left internal mammary artery for...
Poor long-term patency rates...
08/01/2008
Journal of Invasive Cardiology
Late Superior Vena Cava Perforation and Aortic Laceration After Stent Placement for Treatment of Superior Vena Cava Syndrome Sec
08/01/2008
Michael R. Recto, MD; Thomas Yeh, Jr., MD, PhD; Michael Bousamra, MD
Stent implantation has long been used to treat many types of vascular stenoses. Stents were initially used in the late 1980’s to treat patients with branch pulmonary artery stenoses.1–3 In the 1990’s, stents were used to relieve right...
Stent implantation has long been used to treat many types of vascular stenoses. Stents were initially used in the late 1980’s to treat patients with branch pulmonary artery stenoses.1–3 In the 1990’s, stents were used to relieve right...
Stent implantation has long been...
08/01/2008
Journal of Invasive Cardiology
Diabetic Retinopathy as a Predictor of Late Clinical Events Following Percutaneous Coronary Intervention<br />
08/01/2008
Myeong-Ki Hong, MD; Young-Hak Kim, MD; Cheol-Whan Lee, MD, PhD; Jong-Min Song, MD, PhD; Ki-Hoon Han, MD, PhD; Duk-Hyun Kang, MD, PhD; Jae-Kwan Song, MD, PhD; Jae-Joong Kim, MD, PhD; Seong-Wook Park, MD, PhD; Seung-Jung Park, MD, PhD
Coronary artery disease is frequently encountered in diabetic patients.1 Previous reports showed that 15–25% of patients undergoing coronary revascularization had diabetes mellitus (DM).2–4 Although the initial success and in-hospital...
Coronary artery disease is frequently encountered in diabetic patients.1 Previous reports showed that 15–25% of patients undergoing coronary revascularization had diabetes mellitus (DM).2–4 Although the initial success and in-hospital...
Coronary artery disease is...
08/01/2008
Journal of Invasive Cardiology
Supplemental Value of Troponin I Combined With a Clinical Risk Model to Predict In-Hospital Events in Intermediate- and High-Ris
08/01/2008
Barry Merrill, MD; Lloyd W. Klein, MD; James E. Calvin, MD
The term “acute coronary syndrome” (ACS) is applied to a broad spectrum of clinical presentations of chest pain, thus rendering accurate risk stratification crucial to rational decision making. Several clinical characteristics known at...
The term “acute coronary syndrome” (ACS) is applied to a broad spectrum of clinical presentations of chest pain, thus rendering accurate risk stratification crucial to rational decision making. Several clinical characteristics known at...
The term “acute coronary...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Editorial Message October 2002
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, and articles from the Journal special sections “Interventions in Peripheral Disease”, “Acute Coronary Syndromes” and...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, and articles from the Journal special sections “Interventions in Peripheral Disease”, “Acute Coronary Syndromes” and...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

News

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
Murai Figure
Clinical Videos
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to...
04/09/2025
Journal of Invasive Cardiology
Clinical Images
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Keima Wayama, MD; Kota Murai, MD, PhD; Teruo Noguchi, MD, PhD
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a...
04/09/2025
Journal of Invasive Cardiology
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Agstam Figure
Clinical Videos
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to...
04/07/2025
Journal of Invasive Cardiology
Clinical Images
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Venkatakrishnan Ramakumar, MD, DM; Durlabhesh Rawat, MD, DM; Sourabh Agstam, MD, DM
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human...
04/07/2025
Journal of Invasive Cardiology
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Original Contribution
Rotational Atherectomy for Calcified Coronary Lesions in Severe Aortic Stenosis Before Transcatheter Aortic Valve Implantation
04/04/2025
Sultan Alotaibi, MD, MSc; Abdelhakim Allali, MD; Hajo Heyer, MD; Nader Mankerious, MD; Martin Landt, MD; Mohamed Abdel-Wahab, MD; Volker Geist, MD; Ralph Tölg, MD; Mohamed Samy, MD; Gert Richardt, MD; Karim Elbasha, MD
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare...
04/04/2025
Journal of Invasive Cardiology
Original Contribution
Can IodixAnol ReducE the Incidence of Adverse Renal or Cardiac Events in Chronic Total Occlusion Interventions (CARE-CTO): A Substudy of the PROGRESS-CTO Registry
04/02/2025
Dimitrios Strepkos, MD; Athanasios Rempakos, MD; Michaella Alexandrou, MD; Deniz Mutlu, MD; Pedro E.P. Carvalho, MD; Ozgur Selim Ser, MD; Khaldoon Alaswad, MD; Mir Babar Basir, DO; Dmitrii Khelimskii, MD; Oleg Krestyaninov, MD; Jaikirshan J. Khatri, MD; Laura D. Young, MD; Omer Goktekin, MD; Paul Poommipanit, MD; Farouc A. Jaffer, MD, PhD; Sevket Gorgulu, MD; Ahmed M. ElGuindy, MD; Nidal Abi Rafeh, MD; Olga C. Mastrodemos, BA; Bavana V. Rangan, BDS, MPH; Sandeep Jalli, DO; Konstantinos Voudris, MD, PhD; Yader Sandoval, MD; M. Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in...
04/02/2025
Journal of Invasive Cardiology

October 2002 Volume 14 Issue 11

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use